Passage Bio Inc (PASG) Stock Price, Quote, News & History

PASGNASDAQ
$5.84
-0.06-1.02%
At close: Apr 24, 5:00 PM EST
$5.78
-0.06-1.03%
After Hours: 7:43 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-31.51M
Investing Cash Flow (TTM)
40.22M
Financing Cash Flow (TTM)
23.00K
Free Cash Flow (TTM)
-31.51M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
8.73M

Analyst Trends and Forecast

1
Nov 25
2
Mar
1
2
Apr
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$3.56M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.01
Earnings Yield % (TTM)
-243.43%
Earnings Yield % (FWD)
-243.60%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$5.85

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$46.30M
Debt to Equity
1.28
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$5.87
Close
$5.84
Volume / Avg.
56.36K / 69.01K
Day Range
$5.73 - $6.00
52 Wk Range
5.12 - 20.00
Market Cap
$18.37M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
36
Short Interest
4.86%
Days to Cover
3.16

About

Sector
Health Care
Industry
Biotechnology
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to targ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Passage Bio (PASG) stock?

A

You can purchase shares of Passage Bio (NASDAQ:PASG) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Passage Bio (PASG) competitors?

A

There are no as such competitors for Passage Bio.

Q

What is the forecast, or price target, for Passage Bio (PASG) stock?

A

Passage Bio has a consensus price target of $12.00.

Q

What is the current price for Passage Bio (PASG)?

A

The stock price for Passage Bio (NASDAQ: PASG) is $5.78 last updated April 24, 2026 at 7:43 PM EDT.

Q

Does Passage Bio (PASG) pay a dividend?

A

There are no upcoming dividends for Passage Bio.

Q

When is Passage Bio (NASDAQ:PASG) reporting earnings?

A

Passage Bio does not have any upcoming earnings scheduled.

Q

Is Passage Bio (PASG) going to split?

A

There is no upcoming split for Passage Bio.

Q

What sector and industry does Passage Bio (PASG) operate in?

A

Passage Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.